Last reviewed · How we verify

NCT04759560

Biometric Characteristics of the Eye With Microcornea/Microphthalmia and Congenital Cataract Before And After Cataract Extraction

Status unknown Last updated 21 February 2021
What this trial tests

trial in Congenital Cataract in 133 participants. Status unknown.

Timeline
25 July 2020
Primary endpoint
25 July 2021
1 September 2021

Quick facts

Lead sponsorAlexandria University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment133
Start date25 July 2020
Primary completion25 July 2021
Estimated completion1 September 2021
Sites1 location across Egypt

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 3 Months to 7, any sex, with Congenital Cataract or Microphthalmos. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early cataract surgery in microcornea/microphthalmia eyes is essential to prevent amblyopia and improve visual outcomes, including stereopsis. However, despite recent advances in pediatric cataract microsurgical techniques, this surgery remains challenging owing to several intraoperative difficulties attributable to the crowded anterior segment in these small, soft, and poorly developed eyes with shallow anterior chambers, and poor pupillary dilation. In this study the investigator aim to report on the changes in the anterior segment biometric characteristics after cataract extraction in eyes with microcornea/microphthalmia with congenital cataract.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Cataract

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04759560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing